From the AMCP Policy Digest, AMCP's policies regarding formulary management.
AMCP Position Statements
See how AMCP advocates for you. Stay informed on the latest policy actions and position statements shaping legislation and pharmacy practice so you can understand what’s changing and why it matters for your work in managed care pharmacy.
Shaping Practice Standards in Managed Care Pharmacy
AMCP’s nearly 8,000 members work to improve the health of more than 200 million Americans through managed care pharmacy. Our Position Statements reflect AMCP’s stance on key professional and practice issues, guiding members in their roles and supporting advocacy with policymakers and stakeholders. Approved by the AMCP Board of Directors, these concise statements help define the responsibilities of managed care pharmacists, ensuring medications are used safely, effectively, and affordably.
From the AMCP Policy Digest, AMCP's policies regarding research.
AMCP supports efforts to reduce fraud, waste, and abuse in prescription drug benefit plans
The Academy of Managed Care Pharmacy (AMCP) supports an abbreviated licensure pathway for the approval of biosimilar biologic drug therapies.
AMCP believes that a health care delivery system that is based upon a competitive marketplace will provide greater value to patients and payers than a system that is one‐size‐fits‐all that relies on centralized governmental controls and regulatory mandates.
AMCP opposes statutory and regulatory proposals that unduly restrict the ability of pharmacists working within managed care organizations from utilizing tools and services that are essential for the management of a prescription drug benefitFind out about Regulation of the Prescription Drug Benefit.
AMCP stands against racial and health care injustice. AMCP is committed to 1) mitigating disparities related to optimal medication use, 2) advancing conversations by calling for pertinent submissions to the Journal of Managed Care + Specialty Pharmacy (JMCP) and conducting partnership forum(s), 3) incorporating health equity goals into the strategic plan, and 4) supporting impactful education and policy.
AMCP supports the use of preferred pharmacy networks as a way of providing additional options to incentivize higher quality care and improve cost-effectiveness.
AMCP believes that to provide the greatest value to Americans who need prescription drugs, market forces must effectively ensure that manufacturers of similar drugs compete with one another to establish reasonable pricing levels and maintain consumer access to needed therapies. While government has a responsibility to protect consumers against anti-competitive activity, the government must not establish rules that have the unintended effect of undermining competition.
AMCP supports the use of MAC pricing as a managed care tool to encourage the dispensing of cost saving generic drugs and thereby benefiting the overall health care system.
From the AMCP Policy Digest, AMCP's policies regarding dispensing issues.
AMCP supports off‐label use of FDA‐approved drugs when medically appropriate and necessary, but opposes government‐mandated coverage of specific pharmaceuticals, whether for FDA‐approved or off‐label uses.
